Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissue.
Lein
M
M
Department of Urology, University Hospital Charité, Humboldt University, Berlin, Germany.
Nowak
L
L
Jung
K
K
Laube
C
C
Ulbricht
N
N
Schnorr
D
D
Loening
S A
SA
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000097:blood; D017364:Collagenases / Q000032:analysis* / Q000097:blood; D006801:Humans; D008297:Male; D020781:Matrix Metalloproteinase 1; D008666:Metalloendopeptidases / Q000032:analysis* / Q000097:blood; D009362:Neoplasm Metastasis; D011470:Prostatic Hyperplasia / Q000097:blood / Q000378:metabolism / Q000473:pathology; D011471:Prostatic Neoplasms / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D012016:Reference Values; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000032:analysis* / Q000097:blood
D014408:Biomarkers, Tumor; D019715:Tissue Inhibitor of Metalloproteinase-1; D017364:Collagenases; D008666:Metalloendopeptidases; D020781:Matrix Metalloproteinase 1